Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Pharmacoeconomics|November 10, 2001
The burden of asthma and chronic obstructive pulmonary disease: data from The NetherlandsM P Rutten van-Mölken, T L Feenstra
Pharmacoeconomics|May 27, 1999
Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthmaM P Rutten-van Mölken, E K van Doorslaer, M D Till
Journal of Glaucoma|July 10, 2001
Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the NetherlandsJ B Oostenbrink, M P Rutten-van Mölken, T S Sluyter-Opdenoordt
Health Economics|September 1, 1994
Statistical analysis of cost outcomes in a randomized controlled clinical trialM P Rutten-van Mölken, E K van Doorslaer, R C van Vliet
The European Respiratory Journal|July 3, 2010
Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approachM Hoogendoorn, R T Hoogenveen, M P Rutten-van Mölken, et al.
Journal of Clinical Epidemiology|August 15, 2000
The cost diary: a method to measure direct and indirect costs in cost-effectiveness researchM E Goossens, M P Rutten-van Mölken, J W Vlaeyen, et al.
Pain|April 16, 1999
Patient utilities in chronic musculoskeletal pain: how useful is the standard gamble method?M E Goossens, J W Vlaeyen, M P Rutten-van Mölken, et al.
Medical Care|September 1, 1995
Methodological issues of patient utility measurement. Experience from two clinical trialsM P Rutten-van Mölken, C H Bakker, E K van Doorslaer, et al.
Pageof 3